Table 2.

The effect of intraperitoneal NGF (IP NGF) or intrathecal NGF on the percentage of BDNF-expressing DRG cells that also exhibit trkA or CGRP immunoreactivity

ControlIP NGFIntrathecal NGF
% of BDNF expressing other% of other expressing BDNF% of BDNF expressing other% of other expressing BDNF% of BDNF expressing other% of other expressing BDNF
BDNF and trkA immunoreactivities46% (200/434)21% (200/931)49% (207/421)29% (207/721)91% (201/221)84% (201/268)
BDNF and CGRP immunoreactivities68% (131/192)20% (131/644)44% (227/511)21% (227/1088)96% (322/335)76% (322/424)
BDNF mRNA and trkA immunoreactivity44% (301/507)30% (301/810)80% (900/1241)60% (900/1311)79% (540/685)88% (540/603)
  • The figures in brackets indicate the number of cells counted.